دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Unveiling melanomagenesis through the dermatoscope
C. Navarrete-Dechent, N. Jaimes, M.A. Marchetti
doi : 10.1111/jdv.17244
Volume 35, Issue 5 p. 1038-1039
Despite cutaneous melanoma being a common cancer, controversies persist regarding its genesis and particularly its association with melanocytic nevi. Although it is well accepted that nevi are strong phenotypic risk factors for melanoma, their role as cancer precursors is debated. Some suggest that all melanomas arise from a pre-existing nevus [nevus-associated melanoma (NAM)], with the risk of any one nevus transforming to melanoma being extremely low, but others contend that most do not [de novo melanoma (DNM)]. The distinction between NAM and DNM to date has largely relied on histopathological examination, and when applying this criterion, an associated nevus can be identified in up to one-third of cases.1 Studies including those with in vivo imaging techniques such as dermoscopy have subsequently found significant differences in the demographics, phenotype, anatomical location, melanoma subtype, thickness and mutation profiles between NAM and DNM, suggesting that these entities may be biologically unique.1-3
Melanocytic lesions with peripheral globules: still a pitfall in the differential diagnosis of melanoma
E. Lazaridou, C. Fotiadou, Z. Apalla
doi : 10.1111/jdv.17239
Volume 35, Issue 5 p. 1040-1040
It is well known today that the dermoscopic patterns of naevi are associated with various factors including body location, phototype, but also age. Children and young adolescents exhibit most commonly a globular naevus pattern, while in adults the reticular pattern predominates.1 On the other hand, naevi are dynamic neoplasms and symmetric naevus growth is considered as a normal phenomenon in their life cycle, especially in young people.2 However, change in melanocytic skin lesions is quite often a concerning feature of malignancy; thus, it is really important to distinguish between normal and abnormal growth, in order not only to reduce unnecessary excisions, but also to decrease underdiagnosis of melanoma in younger patients.
Pioneers in Dermatology and Venereology: An Interview with Professor Peter van de Kerkhof
P.C.M. van de Kerkhof
doi : 10.1111/jdv.17231
Volume 35, Issue 5 p. 1041-1042
2021 European guideline on HIV testing in genito-urinary medicine settings
D. G?kengin, E. Wilson-Davies, A. Nazl? Zeka, A. Palfreeman, J. Begovac, N. Dedes, O. Tarashenko, M. Stevanovic, R. Patel
doi : 10.1111/jdv.17139
Volume 35, Issue 5 p. 1043-1057
Testing for HIV is critical for early diagnosis of HIV infection, providing long-term good health for the individual and prevention of onward transmission if antiretroviral treatment is initiated early. The main purpose of the 2021 European Guideline on HIV Testing in Genito-Urinary Settings is to provide advice on testing for HIV infection in individuals aged 16 years and older who present to sexually transmitted infection, genito-urinary or dermato-venereology clinics across Europe. The guideline presents the details of best practice and offers practical guidance to clinicians and laboratories to identify and offer HIV testing to appropriate patient groups.
Itch processing in the brain
P. Najafi, O. Dufor, D. Ben Salem, L. Misery, J.-L. Carré
doi : 10.1111/jdv.17029
Volume 35, Issue 5 p. 1058-1066
Itch is a sensation defined as the urge to scratch. The central mechanisms of itch are being increasingly studied. These studies are usually based on experimental itch induction methods, which can be classified into the following categories: histamine-induced, induction by other non-histamine chemicals (e.g. cowhage), physically induced (e.g. electrical) and mentally induced (e.g. audio-visual). Because pain has been more extensively studied, some extrapolations to itch can be proposed and verified by experiments. Recent studies suggest that the itch-processing network in the brain could be disrupted in certain diseases. This disruption could be related to the implication of new regions or the exclusion of already engaged brain regions from itch-processing network in the brain.
Trichodysplasia spinulosa: a comprehensive review of the disease and its treatment
P. Curman, A. N?sman, H. Brauner
doi : 10.1111/jdv.17081
Volume 35, Issue 5 p. 1067-1076
Trichodysplasia spinulosa (TS) is a rare dermatological disease caused by TS-associated polyomavirus (TSPyV) in immunosuppressed patients. The seroprevalence of TSPyV in immunocompetent adults is high and the number of immunosuppressed patients developing TS remains low, suggesting that TS is underdiagnosed and/or that additional unknown factors are needed in order to develop TS. There is no well-established treatment for TS, and to date a majority of reported cases have consequently received ineffective therapies, likely due to the unavailability of reviews and recommendations of treatments for TS. The few treatments reported in case reports to be effective include topical cidofovir 3%, reduction of immunosuppression and oral valganciclovir. In this comprehensive review, we present all published cases to date, together with a summary of all treatments for TS categorized by overall clinical efficacy, thus addressing this rare disease and what appears to be its clinically efficacious treatment.
Donor to recipient ratios in the surgical treatment of vitiligo and piebaldism: a systematic review
V.S. Narayan, L.L.C. van den Bol, N. van Geel, M.W. Bekkenk, R.M. Luiten, A. Wolkerstorfer
doi : 10.1111/jdv.17108
Volume 35, Issue 5 p. 1077-1086
Stabilized vitiligo resistant to conventional therapy (e.g. segmental vitiligo) and piebaldism lesions can be treated with autologous cellular grafting techniques, such as non-cultured cell suspension transplantation (NCST) and cultured melanocyte transplantation (CMT). These methods are preferred when treating larger surface areas due to the small amount of donor skin needed. However, the donor to recipient expansion ratios and outcomes reported in studies with cellular grafting vary widely, and to date, no overview or guideline exists on the optimal ratio. The aim of our study was to obtain an overview of the various expansion ratios used in cellular grafting and to identify whether expansion ratios affect repigmentation and colour match. We performed a systematic literature search in MEDLINE and EMBASE to review clinical studies that reported the expansion ratio and repigmentation after cellular grafting. We included 31 eligible clinical studies with 1591 patients in total. Our study provides an overview of various expansion ratios used in cellular grafting for vitiligo and piebaldism, which varied from 1:1 up to 1:100. We found expansion ratios between 1:1 and 1:10 for studies investigating NCST and from 1:20 to 1:100 in studies evaluating CMT. Pooled analyses of studies with the same expansion ratio and repigmentation thresholds showed that when using the lowest (1:3) expansion ratio, the proportion of lesions achieving >50% or >75% repigmentation after NCST was significantly better than when using the highest (1:10) expansion ratio (?2 P = 0.000 and ?2 P = 0.006, respectively). Less than half of our included studies stated the colour match between different expansion ratios, and results were variable. In conclusion, the results of our study indicate that higher expansion ratios lead to lower repigmentation percentages after NCST treatment. This should be taken into consideration while determining which expansion ratio to use for treating a patient.
Dynamic optical coherence tomography shows characteristic alterations of blood vessels in malignant melanoma
J. Welzel, S. Schuh, N. De Carvalho, L. Themstrup, M. Ulrich, G.B.E. Jemec, J. Holmes, G. Pellacani
doi : 10.1111/jdv.17080
Volume 35, Issue 5 p. 1087-1093
Dynamic optical coherence tomography (D-OCT) allows in vivo visualization of blood vessels in the skin and in malignant tumours. Vessel patterns in malignant melanoma may be associated with tumour stage.
Clinical utility of skin cancer and melanoma risk scores for population screening: TRoPICS study
A. Shetty, M. Janda, K. Fry, S. Brown, B. Yau, L. Von Schuckmann, S. Thomas, J.E. Rayner, L. Spelman, G. Wagner, H. Jenkins, K. Lun, J. Parbery, H.P. Soyer, R.E. Neale, A.C. Green, D.C. Whiteman, C.M. Olsen, K. Khosrotehrani
doi : 10.1111/jdv.17062
Volume 35, Issue 5 p. 1094-1098
Screening for skin cancer can be cost-effective if focused on high-risk groups. Risk prediction tools have been developed for keratinocyte cancers and melanoma to optimize advice and management. However, few have been validated in a clinical setting over the past few years.
Line-field confocal optical coherence tomography of basal cell carcinoma: a descriptive study
M. Suppa, M. Fontaine, G. Dejonckheere, E. Cinotti, O. Yélamos, G. Diet, L. Tognetti, M. Miyamoto, C. Orte Cano, J. Perez-Anker, V. Panagiotou, A.L. Trepant, J. Monnier, V. Berot, S. Puig, P. Rubegni, J. Malvehy, J.L. Perrot, V. del Marmol
doi : 10.1111/jdv.17078
Volume 35, Issue 5 p. 1099-1110
Early diagnosis and subtype classification of basal cell carcinoma (BCC) are crucial to reduce morbidity and optimize treatment. Good accuracy in differentiating BCC from clinical imitators has been achieved with existing diagnostic strategies but lower performance in discriminating BCC subtypes. Line-field confocal optical coherence tomography (LC-OCT) is a new technology able to combine the technical advantages of reflectance confocal microscopy and OCT.
The differences in clinical and dermoscopic features between in situ and invasive nevus-associated melanomas and de novo melanomas
O. Reiter, N. Kurtansky, J.K. Nanda, K.J. Busam, A. Scope, S. Musthaq, A.A. Marghoob
doi : 10.1111/jdv.17133
Volume 35, Issue 5 p. 1111-1118
Nevus-associated melanomas (NAM) account for 30% of all melanomas and are associated with younger age and with thinner Breslow thickness. Previous studies of NAM dermoscopy found conflicting results.
Which medical disciplines diagnose and treat melanoma in Europe in 2019? A survey of experts from melanoma centres in 27 European countries
L. Kandolf-Sekulovic, K. Peris, A. Stratigos, A. Hauschild, A.-M. Forsea, C. Lebbe, A. Lallas, J.-J. Grob, C. Harwood, H. Gogas, P. Rutkowski, J. Olah, N.W.J. Kelleners-Smeets, J. Paoli, R. Dummer, D. Moreno-Ramirez, L. Bastholt, K. Putnik, R. Karls, C. Hoeller, V. Vandersleyen, R. Vieira, P. Arenberger, M. Bylaite-Buckinskiene, J. Ocvirk, M. Situm, G. Weinlich, M. Banjin, V. Todorovic, A. Ymeri, A. Zhukavets, C. Garbe
doi : 10.1111/jdv.17086
Volume 35, Issue 5 p. 1119-1132
The incidence of melanoma is increasing. This places significant burden on societies to provide efficient cancer care. The European Cancer Organisation recently published the essential requirements for quality melanoma care. The present study is aimed for the first time to roughly estimate the extent to which these requirements have been met in Europe.
Melanocytic lesions with peripheral globules: results of an observational prospective study in 154 high-risk melanoma patients under digital dermoscopy follow-up evaluated with reflectance confocal microscopy
A. Pamp?n-Franco, R. Gamo-Villegas, U. Florist?n-Muruz?bal, F.J. Pinedo-Moraleda, E. Pérez-Fern?ndez, J.L. L?pez-Estebaranz
doi : 10.1111/jdv.17105
Volume 35, Issue 5 p. 1133-1142
The management of melanocytic lesions with peripheral globules (MLPGs) is usually age-dependent and can be challenging in high-risk melanoma patients.
First-in-human study demonstrating the safety and clinical efficacy of novel anti-IL-17A monoclonal antibody CJM112 in moderate to severe plaque psoriasis
M. Kaul, P. Jarvis, I. Rozenberg, F. Kolbinger, F. Di Padova, C. Calonder, P. Espie, J.M. Rondeau, R. Cebe, T. Huber, R. Mussmann, M. Aassi, T.S. Sligh
doi : 10.1111/jdv.17071
Volume 35, Issue 5 p. 1143-1151
Anti-IL-17A IgG/? monoclonal antibody CJM112 binds both IL-17A and IL-17AF. The purpose of this First-in-Human study was to assess CJM112 effects on safety and efficacy in patients with moderate to severe plaque psoriasis.
Long-term safety and efficacy of a fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion in moderate-to-severe plaque psoriasis: phase 3 open-label study
M.G. Lebwohl, L. Stein Gold, K. Papp, G. Han, D.M. Pariser, T. Lin, S. Harris, A. Jacobson
doi : 10.1111/jdv.17113
Volume 35, Issue 5 p. 1152-1160
The topical corticosteroid halobetasol propionate (HP) and the retinoid tazarotene (TAZ) are effective in psoriasis treatment. To mitigate adverse cutaneous reactions observed with monotherapy, a fixed- combination HP 0.01%/TAZ 0.045% lotion has been developed for the treatment of plaque psoriasis in adults.
Network meta-analysis of biologic treatments for psoriasis using absolute Psoriasis Area and Severity Index values ?1, 2, 3 or 5 derived from a statistical conversion method
U. Mrowietz, R.B. Warren, C.L. Leonardi, D. Saure, H. Petto, S. Hartz, M. Dossenbach, K. Reich
doi : 10.1111/jdv.17130
Volume 35, Issue 5 p. 1161-1175
In practice, the goal of treatment for patients with psoriasis is to achieve almost clear or clear skin and maintain disease control, regardless of baseline disease severity. However, identifying absolute Psoriasis Area and Severity Index (PASI) values for new treatment goals is challenging, as most clinical trials report relative PASI 50, 75, 90 or 100 improvements but rarely absolute PASI values achieved.
Pruritus Intensity Scales across Europe: a prospective validation study
M. Storck, S. Sandmann, P. Bruland, M.P. Pereira, S. Steinke, C. Riepe, I. Soto-Rey, S. Garcovich, M. Augustin, C. Blome, S. Bobko, F.J. Legat, N. Potekaev, A. Lvov, L. Misery, W. Weger, A. Reich, E. ?avk, M. Streit, E. Serra-Baldrich, J.C. Szepietowski, M. Dugas, S. St?nder, C. Zeidler
doi : 10.1111/jdv.17111
Volume 35, Issue 5 p. 1176-1185
Chronic pruritus (CP) is a subjective symptom, and it is necessary to assess its intensity with validated patient-reported outcome tools in order to allow determination of the treatment course.
Stratum corneum markers of innate and T helper cell-related immunity and their relation to the disease severity in Croatian patients with atopic dermatitis
R. Jurakic Toncic, I. Jakasa, Y. Sun, G. Hurault, S. Ljubojevic Hadzavdic, R. J. Tanaka, B. Pavicic, A. Balic, K. Zuzul, M. Petkovic, S. Kezic, B. Marinovic
doi : 10.1111/jdv.17132
Volume 35, Issue 5 p. 1186-1196
Atopic dermatitis (AD) presents with the wide spectrum of clinical phenotypes within and between various populations. Recent study showed low frequency of filaggrin loss-of-function (FLG LOF) mutations in Croatian AD patients. At present, there are no data on biomarkers of immune response in Croatian AD patients that might be useful in the selection and monitoring of novel immune therapies.
Incidence of pemphigoid diseases in Northern Germany in 2016 – first data from the Schleswig-Holstein Registry of Autoimmune Bullous Diseases
N. van Beek, A. Weidinger, S.W. Schneider, A. Kleinheinz, R. Gl?ser, M.M. Holtsche, A. von Georg, C.M. Hammers, F. Hübner, A.-L. Lima, D. Gola, C.D. Sadik, D. Zillikens, A. Katalinic, E. Schmidt, I.R. K?nig
doi : 10.1111/jdv.17107
Volume 35, Issue 5 p. 1197-1202
Autoimmune bullous diseases (AIBD) are rare disorders characterized by autoantibody formation against components of adhesion molecules; in pemphigoid diseases (PD), these are proteins of hemidesmosomes and basement membrane, important for cell-matrix adhesion in skin and/or mucous membranes. Incidences of these diseases vary considerably between different populations.
Full exome sequencing of 11 families with Hidradenitis suppurativa
P. Theut Riis, I.C. Loft, S. Yazdanyar, R. Kj?rsgaard Andersen, O.B. Pedersen, H.C. Ring, R. Huber, M. Sultan, C. Loesche, D.M.L. Saunte, G.B.E. Jemec
doi : 10.1111/jdv.17095
Volume 35, Issue 5 p. 1203-1211
Hidradenitis suppurativa (HS) is not a well-studied or easily treated disease. Genetic information is essential for advances in the understanding and treatment of HS. This study aims to examine mutations in the gamma-secretase complex, the Notch signalling pathway and to perform a Mendelian analysis of genetic variants that segregated with disease in a full exome sequencing of 11 families with HS.
Impact of acne on the daily life of adult patients: building a self-administered patient questionnaire
B. Dréno, A. Khammari, S. Seité, C. Legrand, B. Halioua, L. Misery, K. Ezzedine, J. Shourick, C. Taieb
doi : 10.1111/jdv.17134
Volume 35, Issue 5 p. 1212-1218
Acne is a long-lasting disease in adolescents and adults impacting the patient’s daily life. Currently, there is no specific questionnaire that assesses its impact in adult patients.
Human Papillomavirus-type distribution in anogenital lesions of prepubertal children
S.A. Braun, S. Silling, S.M. Schloer, S.C. Hofmann, B. Fritzen, F. Oellig, P. Lehmann, B. Homey, C. Assaf, S. Emmert, R. F?lster-Holst, C. Tigges, U. Wieland, A. Kreuter
doi : 10.1111/jdv.17114
Volume 35, Issue 5 p. 1219-1225
In contrast to adults, only limited data are available on the human papillomavirus (HPV)-type spectrum in anogenital warts (AGW) of children.
Miliary fibromas in tuberous sclerosis complex
A.M. Cartron, D. Buccine, A.M. Treichel, C.R. Lee, J. Moss, T.N. Darling
doi : 10.1111/jdv.17161
Volume 35, Issue 5 p. 1226-1229
Tuberous sclerosis complex (TSC) is a hamartoma syndrome characterized by multiple skin lesions, such as angiofibromas, shagreen patch and miliary fibromas (MiF).
European Task Force on Atopic Dermatitis: position on vaccination of adult patients with atopic dermatitis against COVID-19 (SARS-CoV-2) being treated with systemic medication and biologics
J.P. Thyssen, C. Vestergaard, S. Barbarot, M.S. de Bruin-Weller, T. Bieber, A. Taieb, J. Seneschal, M.J. Cork, C. Paul, C. Flohr, S. Weidinger, M. Trzeciak, T. Werfel, A. Heratizadeh, U. Darsow, D. Simon, A. Torrelo, P.V. Chernyshov, J.-F. Stalder, C. Gelmetti, Z. Szalai, ?. Svensson, L.B. von Kobyletzki, L. De Raeve, R. F?lster-Holst, S. Christen-Zaech, D.J. Hijnen, U. Gieler, J. Gutermuth, C. Bangert, P.I. Spuls, B. Kunz, J. Ring, A. Wollenberg, M. Deleuran
doi : 10.1111/jdv.17167
Volume 35, Issue 5 p. e308-e311
COVID-19 and HHV8 first spotted together: an affair under electron microscopy
E. Leoni, M. Cerati, G. Finzi, M. Lombardo, F. Sessa
doi : 10.1111/jdv.17123
Volume 35, Issue 5 p. e311-e312
COVID-19 and immune checkpoint inhibitors
M.S. Ahmed, H. Brehme, S. Friedrich, L. Reinhardt, S. Blum, S. Beissert, F. Meier
doi : 10.1111/jdv.17172
Volume 35, Issue 5 p. e312-e314
Relapse of chilblain-like lesions during the second wave of coronavirus disease 19
S. Recalcati, T. Barbagallo, S. Tonolo, M. Milani, F. Fantini
doi : 10.1111/jdv.17168
Volume 35, Issue 5 p. e315-e316
Chilblain-like lesions and COVID-19: second wave, second outbreak
V. Piccolo, A. Bassi, T. Russo, C. Mazzatenta, M. Baraldi, G. Argenziano, I. Neri, M. Cutrone
doi : 10.1111/jdv.17145
Volume 35, Issue 5 p. e316-e318
Absence of SARS-CoV-2 RNA detection in tissue samples of COVID-19-related cutaneous lesions analyzed by real-time RT-PCR
M. F. Garc?a-Gil, J. Monte-Serrano, M. Garc?a Garc?a, L. Prieto-Torres, A. J. Pascual-del-Riquelme, I. Casas Flecha, M. Ara-Mart?n
doi : 10.1111/jdv.17146
Volume 35, Issue 5 p. e318-e321
Successful treatment of recalcitrant genital lichen planus with secukinumab
C. Rezzag-Mahcene, N. Cardot-Leccia, J.-P. Lacour, H. Montaudié, T. Passeron
doi : 10.1111/jdv.17068
Volume 35, Issue 5 p. e321-e323
Metronidazole for Hidradenitis Suppurativa: future potential treatment applications
H.C. Ring, A. Knudsen, S.F. Thomsen
doi : 10.1111/jdv.17069
Volume 35, Issue 5 p. e323-e324
Epidermal biomarker levels differentiate lesional from non-lesional skin and show variation across anatomical locations in patients with atopic dermatitis
J.G. Holm, M.L. Clausen, T. Agner, N.S. Arildsen, I. Jakasa, S. Kezic, S.F. Thomsen
doi : 10.1111/jdv.17070
Volume 35, Issue 5 p. e325-e327
Spontaneous resolution of multidrug-resistant Mycobacterium abscessus infection in tattoo
E.M.M. Oyen, K.I. Maijer, S.A.S. van der Bent, J.M. Prins, S. Janssen, S. Kuipers, H.J.C. De Vries
doi : 10.1111/jdv.17072
Volume 35, Issue 5 p. e328-e330
Hyperspectral measurement of skin reflectance detects differences in the visible and near-infrared regions according to race, gender and body site
J. Tsai, A.L. Chien, J.U. Kang, S. Leung, S. Kang, L.A. Garza
doi : 10.1111/jdv.17076
Volume 35, Issue 5 p. e330-e333
Sunshine on ‘Zebra People’
Mandibular sterile osteitis as a manifestation of synovitis, acne, pustulosis, hyperostosis, osteitis syndrome: a literature review
doi : 10.1111/jdv.17088
Volume 35, Issue 5 p. e333-e335
Mandibular sterile osteitis as a manifestation of synovitis, acne, pustulosis, hyperostosis, osteitis syndrome: a literature review
C. Klein, D. Lipsker
doi : 10.1111/jdv.17089
Volume 35, Issue 5 p. e335-e338
Neurokinin-1 receptor antagonist tradipitant has mixed effects on itch in atopic dermatitis: results from EPIONE, a randomized clinical trial
S.E. Welsh, C. Xiao, A.R. Kaden, J.L. Brzezynski, M.A. Mohrman, J. Wang, S.P. Smieszek, B. Przychodzen, S. St?nder, C. Polymeropoulos, G. Birznieks, M.H. Polymeropoulos
doi : 10.1111/jdv.17090
Volume 35, Issue 5 p. e338-e340
Effectiveness and safety of guselkumab in 50 patients with moderate to severe plaque psoriasis who had previously been treated with other biologics: a retrospective real-world evidence study
J.F.B. Schwensen, V.W. Nielsen, C.V. Nissen, C. Sand, R. Gniadecki, S.F. Thomsen
doi : 10.1111/jdv.17092
Volume 35, Issue 5 p. e341-e343
Decreased melanocyte counts in the upper hair follicle in frontal fibrosing alopecia compared to lichen planopilaris: a retrospective histopathologic study
A.C. Katoulis, K. Diamanti, V. Damaskou, A. Pouliakis, E. Bozi, N. Koufopoulos, D. Rigopoulos, D. Ioannides, I.G. Panayiotides
doi : 10.1111/jdv.17093
Volume 35, Issue 5 p. e343-e345
MEDNIK-like syndrome due to compound heterozygous mutations in AP1B1
Y. Ito, T. Takeichi, S. Igari, T. Mori, A. Ono, K. Suyama, S. Takeuchi, Y. Muro, T. Ogi, M. Hosoya, T. Yamamoto, M. Akiyama
doi : 10.1111/jdv.17098
Volume 35, Issue 5 p. e345-e347
Antibiotic resistance in acne an emergent need to recognize resistance to azithromycin and restrict its unapproved use in acne vulgaris
K. Sardana, S. R. Mathachan, T. Gupta
doi : 10.1111/jdv.17099
Volume 35, Issue 5 p. e347-e348
Genetic variations in gamma-secretase and PSTPIP1 in hidradenitis suppurativa in Singaporean Chinese
M. Shen, X.L.A. Yeoh, D.Y. Wang, H.L. Tey, E.C. Ren, H.H. Oon
doi : 10.1111/jdv.17125
Volume 35, Issue 5 p. e348-e350
Serological diagnosis of secondary syphilis in a Rituximab-treated patient: an emerging diagnostic challenge?
C. Lefeuvre, A. Croué, P. Abgueguen, M. Letzelter, A. Ducancelle, P. Grange, N. Benhaddou, N. Dupin, H. Le Guillou-Guillemette, C. Le Clec'h
doi : 10.1111/jdv.17126
Volume 35, Issue 5 p. e350-e352
